跳至主要内容
临床试验/JPRN-UMIN000031111
JPRN-UMIN000031111已完成4 期

The efficacy of progestin primed ovarian stimulation (PPOS) during controlled ovarian stimulation(COS) for patients with endometriosis - PPOS for patients with endometriosis

Kamiya Ladies Clinic0 个研究点目标入组 150 人开始时间: 2018年2月5日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
150

研究概览

简要总结

During this study, no premature LH surge was detected. A smaller number of oocytes were retrieved in the dienogest(DNG) group than in the dydrogesterone(DYG) group (6.18 vs. 9.85); however, the rate of mature oocytes was significantly higher in the DNG group than in the DYG group (89.1% vs. 78.9%). The fertilization rate was comparable between two groups. Therefore, patients taking DNG for PPOS can continue endometriosis treatment and obtain good-quality embryos during COH.

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 43years-old(—)
性别
Female

入选标准

  • 未提供

排除标准

  • 1) Patients who documented cycles with no oocyte retrieved, any contraindications to ovarian stimulation treatment and 2) patients who has contraindication to DNG, GnRHa, EP, FSH, HMG, HCG 3) Patients who is judged to be inappropriate for this study by the doctor

研究者

相似试验

The efficacy of progestin primed ovarian stimulation... | 临床试验